Disruptive Innovation in MedTech: Rethinking the Future of Healthcare
The Medical Dialogues Bureau reports from the TCT Conference 2025 in San Francisco.
In October 2025, the Transcatheter Cardiovascular Therapeutics (TCT) 2025 opening session emphasized disruptive innovation as the driving force behind healthcare transformation.
Innovation alone is not enough.
Andrew Cleeland, CEO of Fogarty Innovation, urged the medical community to focus on value-based disruption, looking beyond incremental progress.
Author's summary: Disruptive innovation transforms healthcare.
- Event: TCT Conference 2025
- Location: San Francisco
- Speaker: Andrew Cleeland, CEO of Fogarty Innovation
More News
- Here’s why Utah’s Olympic organizers are in NYC this week
- Pole-mount agrivoltaics project installed at Puerto Rico coffee farm
- Johnson and Johnson to spin off orthopaedics market
- READY, FIRE, AIM: Fly Me to the Moon – Pagosa Daily Post News Events & Video for Pagosa Springs Colorado
- Francis Bacon’s Paris pad honoured with plaque
- Why is the Renters' Rights Bill a hopeless sham for landlords and tenants?
- Trump’s tariffs: any road to relief?
- Neumora Therapeutics, Inc.: Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898
- NITMX, Ant International and Krungthai Bank Expand Payment Connectivity Between Thailand and China via PromptPay | AFP.com
- Older Patients and Women Bear the Brunt of CTD-ILD Burden